Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126296071 | 12629607 | 1 | I | 201604 | 20160420 | 20160808 | 20160808 | EXP | US-PFIZER INC-2016226447 | PFIZER | 57.00 | YR | F | Y | 43.90000 | KG | 20160808 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126296071 | 12629607 | 1 | PS | IBRANCE | PALBOCICLIB | 1 | Oral | 125 MG, CYCLIC (ONCE A DAY FOR THREE WEEKS, AND THEN OFF A WEEK) | N | R09975 | 207103 | 125 | MG | CAPSULE | |||||
| 126296071 | 12629607 | 2 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | TABLET | |||||||
| 126296071 | 12629607 | 3 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
| 126296071 | 12629607 | 4 | SS | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 10 MG, 1X/DAY, NIGHTLY | 0 | 10 | MG | TABLET | QD | ||||||
| 126296071 | 12629607 | 5 | C | LETROZOLE. | LETROZOLE | 1 | Oral | 2.5 MG, 1X/DAY | 0 | 2.5 | MG | TABLET | QD | ||||||
| 126296071 | 12629607 | 6 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | Oral | 1.25 MG, WEEKLY (50,000 UNITS) ONCE A WEEK FOR 16 WEEKS | 0 | 1.25 | MG | CAPSULE | /wk | ||||||
| 126296071 | 12629607 | 7 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0.25 MG, 1X/DAY ONCE AT BEDTIME | 0 | .25 | MG | TABLET | QD | ||||||
| 126296071 | 12629607 | 8 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | Oral | UNK, 1X/DAY | 0 | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126296071 | 12629607 | 1 | Breast cancer |
| 126296071 | 12629607 | 2 | Depression |
| 126296071 | 12629607 | 3 | Anxiety |
| 126296071 | 12629607 | 4 | Insomnia |
| 126296071 | 12629607 | 5 | Adjuvant therapy |
| 126296071 | 12629607 | 6 | Vitamin D deficiency |
| 126296071 | 12629607 | 7 | Anxiety |
| 126296071 | 12629607 | 8 | Vitamin supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126296071 | 12629607 | HO |
| 126296071 | 12629607 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126296071 | 12629607 | Anaemia | |
| 126296071 | 12629607 | Blood sodium decreased | |
| 126296071 | 12629607 | Brain oedema | |
| 126296071 | 12629607 | Breast cancer | |
| 126296071 | 12629607 | Dehydration | |
| 126296071 | 12629607 | Disease progression | |
| 126296071 | 12629607 | Dizziness | |
| 126296071 | 12629607 | Fall | |
| 126296071 | 12629607 | Gingivitis | |
| 126296071 | 12629607 | Head banging | |
| 126296071 | 12629607 | Hypokalaemia | |
| 126296071 | 12629607 | Subdural haematoma | |
| 126296071 | 12629607 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126296071 | 12629607 | 1 | 2015 | 20160804 | 0 | |
| 126296071 | 12629607 | 2 | 2009 | 0 | ||
| 126296071 | 12629607 | 4 | 2015 | 0 | ||
| 126296071 | 12629607 | 5 | 2009 | 0 | ||
| 126296071 | 12629607 | 6 | 201606 | 0 |